Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)

لم يتم العثور على أسماء تجارية مسجلة لهذه المادة الفعالة.

لا توجد ملاحظات أطعمة مسجلة لهذه المادة الفعالة.

• Erenumabمتوسط

  قد يزيد استخدام Erenumab مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من خطر آثار ضارة أو من شدته.

  عرض للمتخصصين

  The risk or severity of adverse effects can be increased when Erenumab is combined with Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

• Theophyllineمتوسط

  قد يرفع تناول Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) مع Theophylline تركيز Theophylline في المصل (الدم).

  عرض للمتخصصين

  The serum concentration of Theophylline can be increased when it is combined with Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

• 2-Methoxyethanolطفيف

  قد يقلل تناول 2-Methoxyethanol مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من فعالية Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

  عرض للمتخصصين

  The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with 2-Methoxyethanol.

• 9-(N-methyl-L-isoleucine)-cyclosporin Aطفيف

  قد يقلل تناول 9-(N-methyl-L-isoleucine)-cyclosporin A مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من فعالية Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

  عرض للمتخصصين

  The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with 9-(N-methyl-L-isoleucine)-cyclosporin A.

• Abataceptطفيف

  قد يقلل تناول Abatacept مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من فعالية Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

  عرض للمتخصصين

  The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Abatacept.

• Abetimusطفيف

  قد يقلل تناول Abetimus مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من فعالية Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

  عرض للمتخصصين

  The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Abetimus.

• Acteosideطفيف

  قد يقلل تناول Acteoside مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من فعالية Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

  عرض للمتخصصين

  The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Acteoside.

• Adalimumabطفيف

  قد يقلل تناول Adalimumab مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من فعالية Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

  عرض للمتخصصين

  The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.

• Afelimomabطفيف

  قد يقلل تناول Afelimomab مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من فعالية Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

  عرض للمتخصصين

  The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Afelimomab.

• Aldesleukinطفيف

  قد يقلل تناول Aldesleukin مع Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) من فعالية Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated).

  عرض للمتخصصين

  The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.